Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-03-13

Clinical Trial Update: Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization

View source ↗

Summary

Clinical trial update describing the evaluation of the PROMUS Element Everolimus-eluting coronary stent system for coronary revascularization in ischemic heart …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROMUS Element Everolimus-Eluting Coronary Stent System (everolimus-eluting coronary stent system)

Snippet

Sponsor: European Cardiovascular Research Center | Conditions: Ischemic Heart Disease, Coronary Artery Stenosis | Status: UNKNOWN